Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Avinger News

    3,85 $ 0,00% +0,00 $
    In : 3,5859 € | 25.04.24 22:00:04 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3ETCZ
    ISIN: US0537348775
    US-Symbol: AVGR
    Typ: Aktie

    Avinger News

    07.03.24 - PR Newswire
    Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys?
    Thinking about buying stock in Onespan, Avinger, Lithium Americas, Geron, or Femasys? PR Newswire
    13.02.24 - PR Newswire
    Thinking about buying stock in Avinger, Cloudflare, Backblaze, Shattuck Labs, or Beamr Imaging?
    Thinking about buying stock in Avinger, Cloudflare, Backblaze, Shattuck Labs, or Beamr Imaging? PR Newswire
    21.09.23 - PR Newswire
    Thinking about buying stock in Neptune Wellness Solutions, Kezar Life Sciences, Avinger, Canopy Growth Corp, or Nio Inc?
    Thinking about buying stock in Neptune Wellness Solutions, Kezar Life Sciences, Avinger, Canopy Growth Corp, or Nio Inc? PR Newswire
    19.09.23 - PR Newswire
    Thinking about buying stock in Limbach Holdings, Avinger, Rackspace Technology, Keller Group, or Hyzon Motors?
    Thinking about buying stock in Limbach Holdings, Avinger, Rackspace Technology, Keller Group, or Hyzon Motors? PR Newswire
    20.05.22 - PR Newswire
    Thinking about buying stock in Nio, Exicure, Avinger, Covetrus, or Rocket Pharmaceuticals?
    Thinking about buying stock in Nio, Exicure, Avinger, Covetrus, or Rocket Pharmaceuticals? PR Newswire
    22.03.22 - PR Newswire
    Thinking about buying stock in Draganfly, Enservco, Avinger, Hall of Fame Resort & Entertainment, or Tcr2 Therapeutics?
    Thinking about buying stock in Draganfly, Enservco, Avinger, Hall of Fame Resort & Entertainment, or Tcr2 Therapeutics? PR Newswire
    15.03.22 - PR Newswire
    Thinking about buying stock in Hycroft Mining, Excellon Resources, Avinger, Pearson, or Arcadia Biosciences?
    Thinking about buying stock in Hycroft Mining, Excellon Resources, Avinger, Pearson, or Arcadia Biosciences? PR Newswire
    12.01.22 - PR Newswire
    Thinking about buying stock in Zynga, Petroleo Brasileiro, Opendoor Technologies, Avinger, or Marathon Digital?
    Thinking about buying stock in Zynga, Petroleo Brasileiro, Opendoor Technologies, Avinger, or Marathon Digital? PR Newswire
    12.01.22 - ACCESSWIRE
    Avinger Announces $7.6 Million Registered Direct Offering
    REDWOOD CITY, CA / ACCESSWIRE / January 12, 2022 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-​stage medical device company marketing the first and only ...
    11.01.22 - ACCESSWIRE
    Avinger Announces 510(k) Clearance for Lightbox 3 Next-Generation Imaging Console
    REDWOOD CITY, CA / ACCESSWIRE / January 11, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-​stage medical device company marketing the first and only intravascular ...
    10.01.22 - PR Newswire
    Thinking about buying stock in Tilray, Avinger, Reliance Global, BioCryst Pharmaceuticals, or Codex DNA?
    Thinking about buying stock in Tilray, Avinger, Reliance Global, BioCryst Pharmaceuticals, or Codex DNA? PR Newswire
    17.11.21 - PR Newswire
    Thinking about buying stock in Avinger, Naked Brand, Bit Brother, Norwegian Cruise Line, or Fisker?
    Thinking about buying stock in Avinger, Naked Brand, Bit Brother, Norwegian Cruise Line, or Fisker? PR Newswire
    17.11.21 - ACCESSWIRE
    Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis
    New indication expands addressable market for Pantheris
    11.11.21 - ACCESSWIRE
    Avinger Reports Third Quarter 2021 Financial Results
    REDWOOD CITY, CA / ACCESSWIRE / November 11, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-​stage medical device company marketing the first and only intravascular ...
    29.10.21 - ACCESSWIRE
    Avinger to Announce Third Quarter Results on November 11, 2021
    REDWOOD CITY, CA / ACCESSWIRE / October 29, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-​stage medical device company marketing the first and only intravascular image-...
    07.10.21 - ACCESSWIRE
    Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
    Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis
    03.02.21 - ACCESSWIRE
    Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ: AVGR)
    NEW YORK, NY / ACCESSWIRE / February 3, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ:AVGR)
    31.08.20 - ACCESSWIRE
    Aegis Capital Corp. acted as Sole Bookrunner on a $5.2 Million Follow-On Offering for Avinger Inc. (NASDAQ: AVGR)
    NEW YORK, NY / ACCESSWIRE / August 31, 2020 / Aegis Capital Corp. acted as Sole Bookrunner on a $5.2 Million Follow-On Offering for Avinger Inc. (NASDAQ:AVGR)
    10.08.20 - ACCESSWIRE
    Aegis Capital Corp. acted as Sole Bookrunner on a $6,000,000 Follow-On Offering for Avinger Inc. (NASDAQ:AVGR)
    NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Aegis Capital Corp. acted as Sole Bookrunner on a $6,000,000 Follow-On Offering for Avinger Inc. (NASDAQ:AVGR)
    29.06.20 - ACCESSWIRE
    Aegis Capital Corp. acted as Sole Bookrunner on a $5,400,000 Follow-On Offering for Avinger Inc. (NASDAQ: AVGR)
    NEW YORK, NY / ACCESSWIRE / June 29, 2020 / Aegis Capital Corp. acted as Sole Bookrunner on a $5,400,000 Follow-On Offering for Avinger Inc. (NASDAQ:AVGR)

    Newssuche

    Videos

    08:40 Uhr +24,14%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »